AAAAAA
Results: 1-25/36
Authors:
PRANZATELLI MR
HUANG YY
TATE E
GOLDSTEIN DS
HOLMES CS
GOLDSTEIN EM
KETNER K
KINAST M
LANGE BM
SANZ A
SHEVELL MI
STANFORD RE
TAFF IP
Citation: Mr. Pranzatelli et al., MONOAMINERGIC EFFECTS OF HIGH-DOSE CORTICOTROPIN IN CORTICOTROPIN-RESPONSIVE PEDIATRIC OPSOCLONUS-MYOCLONUS, Movement disorders, 13(3), 1998, pp. 522-528
Authors:
PRANZATELLI MR
Citation: Mr. Pranzatelli, PERIPHERAL NEUROLOGICAL PARANEOPLASTIC SYNDROMES, Medicamentos de actualidad, 34(7), 1998, pp. 625-639
Authors:
PRANZATELLI MR
Citation: Mr. Pranzatelli, CENTRAL PARANEOPLASTIC NEUROLOGICAL SYNDROMES - PART 2 - PRACTICAL, THEORETICAL AND MECHANISTIC CONSIDERATIONS OF TREATMENT WITH DRUGS AND BIOLOGICALS, Medicamentos de actualidad, 34(6), 1998, pp. 507-523
Authors:
PRANZATELLI MR
Citation: Mr. Pranzatelli, CENTRAL NEUROLOGICAL PARANEOPLASTIC SYNDROMES - PART 1 - CLINICAL-FEATURES, PATHOPHYSIOLOGY AND IMMUNOPHARMACOLOGY, Medicamentos de actualidad, 34(5), 1998, pp. 415-430
Authors:
LAFRENIERE RG
ROCHEFORT DL
CHRETIEN N
ROMMENS JM
COCHIUS JI
KALVIAINEN R
NOUSIAINEN U
PATRY G
FARRELL K
SODERFELDT B
FEDERICO A
HALE BR
COSSIO OH
SORENSEN T
POULIOT MA
KMIEC T
ULDALL P
JANSZKY J
PRANZATELLI MR
ANDERMANN F
ANDERMANN E
ROULEAU GA
Citation: Rg. Lafreniere et al., UNSTABLE INSERTION IN THE 5'-FLANKING REGION OF THE CYSTATIN-B GENE IS THE MOST COMMON MUTATION IN PROGRESSIVE MYOCLONUS EPILEPSY TYPE-1, EPM1, Nature genetics, 15(3), 1997, pp. 298-302
Authors:
PRANZATELLI MR
Citation: Mr. Pranzatelli, SEROTONERGIC DRUGS AND MOVEMENT-DISORDERS IN HUMANS, Medicamentos de actualidad, 33(6), 1997, pp. 379-392
Authors:
PRANZATELLI MR
Citation: Mr. Pranzatelli, MYOCLONIC DISORDERS .2. ANTIMYOCLONIC DRUG SITES AND MECHANISMS OF ACTION, Medicamentos de actualidad, 33(5), 1997, pp. 315-324
Authors:
PRANZATELLI MR
Citation: Mr. Pranzatelli, MYOCLONIC DISORDERS .1. DIAGNOSIS AND PHARMACOTHERAPY, Medicamentos de actualidad, 33(4), 1997, pp. 237-250
Authors:
CONNOLLY AM
PESTRONK A
MEHTA S
PRANZATELLI MR
NOETZEL MJ
Citation: Am. Connolly et al., SERUM AUTOANTIBODIES IN CHILDHOOD OPSOCLONUS-MYOCLONUS SYNDROME - AN ANALYSIS OF ANTIGENIC TARGETS IN NEURAL TISSUES, The Journal of pediatrics, 130(6), 1997, pp. 878-884
Authors:
PRANZATELLI MR
Citation: Mr. Pranzatelli, ANTIDYSKINETIC DRUG-THERAPY FOR PEDIATRIC MOVEMENT-DISORDERS, Journal of child neurology, 11(5), 1996, pp. 355-369
Authors:
PRANZATELLI MR
Citation: Mr. Pranzatelli, ORAL PHARMACOTHERAPY FOR THE MOVEMENT-DISORDERS OF CEREBRAL-PALSY, Journal of child neurology, 11, 1996, pp. 13-22
Authors:
PRANZATELLI MR
DURKIN MM
FARMER M
Citation: Mr. Pranzatelli et al., PLASTIC RESPONSES OF NEONATAL 5-HYDROXYTRYPTAMINE(1B) RECEPTORS TO 5,7-DIHYDROXYTRYPTAMINE LESIONS MAPPED BY QUANTITATIVE AUTORADIOGRAPHY, International journal of developmental neuroscience, 14(5), 1996, pp. 621-629
Authors:
PRANZATELLI MR
GALVAN I
TAILOR PT
Citation: Mr. Pranzatelli et al., HUMAN BRAIN-STEM SEROTONIN RECEPTORS - CHARACTERIZATION AND IMPLICATIONS FOR SUBCORTICAL MYOCLONUS, Clinical neuropharmacology, 19(6), 1996, pp. 507-514
Authors:
PRANZATELLI MR
Citation: Mr. Pranzatelli, THE IMMUNOPHARMACOLOGY OF THE OPSOCLONUS-MYOCLONUS SYNDROME, Clinical neuropharmacology, 19(1), 1996, pp. 1-47
Authors:
PRANZATELLI MR
TATE E
GALVAN I
WHEELER A
Citation: Mr. Pranzatelli et al., CONTROLLED TRIAL OF 5-HYDROXY-L-TRYPTOPHAN FOR ATAXIA IN PROGRESSIVE MYOCLONUS EPILEPSY, Clinical neurology and neurosurgery, 98(2), 1996, pp. 161-164
Authors:
PRANZATELLI MR
Citation: Mr. Pranzatelli, THE PHARMACOLOGY OF ANTIMYOCLONIC DRUGS, Clinical neuroscience, 3(4), 1995, pp. 246-252
Authors:
CONNOLLY AM
PESTRONK A
NOETZEL MJ
METHA S
PRANZATELLI MR
Citation: Am. Connolly et al., AUTOANTIBODIES IN CHILDHOOD OPSOCOLNUS MYOCLONUS SYNDROME, Annals of neurology, 38(3), 1995, pp. 505-505
Authors:
MOTT SH
PACKER RJ
VEZINA LG
KAPUR S
DINNDORF PA
CONRY JA
PRANZATELLI MR
QUINONES RR
Citation: Sh. Mott et al., ENCEPHALOPATHY WITH PARKINSONIAN FEATURES IN CHILDREN FOLLOWING BONE-MARROW TRANSPLANTATIONS AND HIGH-DOSE AMPHOTERICIN-B, Annals of neurology, 37(6), 1995, pp. 810-814
Authors:
PRANZATELLI MR
HUANG Y
TATE E
STANLEY M
NOETZEL MJ
GOSPE SM
BANASIAK K
Citation: Mr. Pranzatelli et al., CEREBROSPINAL-FLUID 5-HYDROXYINDOLEACETIC ACID AND HOMOVANILLIC-ACID IN THE PEDIATRIC OPSOCLONUS-MYOCLONUS SYNDROME, Annals of neurology, 37(2), 1995, pp. 189-197
Authors:
PRANZATELLI MR
TATE E
HUANG Y
HAAS RH
BODENSTEINER J
ASHWAL S
FRANZ D
Citation: Mr. Pranzatelli et al., NEUROPHARMACOLOGY OF PROGRESSIVE MYOCLONUS EPILEPSY - RESPONSE TO 5-HYDROXY-L-TRYPTOPHAN, Epilepsia, 36(8), 1995, pp. 783-791
Authors:
PAPERO PH
PRANZATELLI MR
MARGOLIS LJ
TATE E
WILSON LA
GLASS P
Citation: Ph. Papero et al., NEUROBEHAVIORAL AND PSYCHOSOCIAL FUNCTIONING OF CHILDREN WITH OPSOCLONUS-MYOCLONUS SYNDROME, Developmental Medicine and Child Neurology, 37(10), 1995, pp. 915-932
Authors:
PRANZATELLI MR
RAZI P
Citation: Mr. Pranzatelli et P. Razi, DRUG-INDUCED REGULATION OF [I-125] IODOCYANOPINDOLOL-LABELED 5-HYDROXYTRYPTAMINE(1B) RECEPTOR-BINDING SITES IN THE CENTRAL-NERVOUS-SYSTEM, Neuropsychopharmacology, 10(4), 1994, pp. 259-264
Authors:
PRANZATELLI MR
MOTT SH
PAVLAKIS SG
CONRY JA
TATE ED
Citation: Mr. Pranzatelli et al., CLINICAL SPECTRUM OF SECONDARY PARKINSONISM IN CHILDHOOD - A REVERSIBLE DISORDER, Pediatric neurology, 10(2), 1994, pp. 131-140
Authors:
PRANZATELLI MR
Citation: Mr. Pranzatelli, PUTATIVE NEUROTRANSMITTER ABNORMALITIES IN INFANTILE SPASMS - CEREBROSPINAL-FLUID NEUROCHEMISTRY AND DRUG EFFECTS, Journal of child neurology, 9(2), 1994, pp. 119-129
Authors:
PRANZATELLI MR
NADI NS
MOODY SA
MAJOR EO
CHUMPITAZI BA
MARUSICK MF
Citation: Mr. Pranzatelli et al., PARANEOPLASTIC AUTOANTIBODY ANTI-HU IS CYTOTOXIC TO CULTURED HUMAN FETAL BRAIN NEURONS IDENTIFIED BY IMMUNOHISTOCHEMISTRY - IMPLICATIONS FOR OPSOCLONUS-MYOCLONUS, Annals of neurology, 36(3), 1994, pp. 502-503